| Jeffrey D Downing, MD | |
|
945 Bethesda Dr, Ste 140, Zanesville, OH 43701-0801 | |
| (740) 454-4040 | |
| (740) 454-4006 |
| Full Name | Jeffrey D Downing |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 41 Years |
| Location | 945 Bethesda Dr, Zanesville, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982704243 | NPI | - | NPPES |
| 0655803 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 35052537D (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Genesis Hospital | Zanesville, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Muskingum Valley Health Centers | 4789760216 | 66 |
News Archive
Baseball season has arrived, but no matter how eager young players are to get on the diamond they have to keep from overdoing it - especially if they're pitchers.
Chronic kidney disease (CKD) affects at least one in four Americans who are older than 60 and can significantly shorten lifespan. Yet the few available drugs for CKD can only modestly delay the disease's progress towards kidney failure. Now, however, a team led by researchers at the Perelman School of Medicine at the University of Pennsylvania, has found an aspect of CKD's development that points to a promising new therapeutic strategy.
A new model developed at MIT can help predict if patients at risk for Alzheimer's disease will experience clinically significant cognitive decline due to the disease, by predicting their cognition test scores up to two years in the future.
Nuance Communications, Inc. today announced PowerScribe 360, an advanced radiology reporting and communications platform that combines the best capabilities of PowerScribe and RadWhere into a unified solution. PowerScribe 360 was designed based on feedback and the extensive experience from Nuance's growing list of radiology customers, which today accounts for more than one third of all radiologists in the United States.
Cancer Research UK scientists have for the first time developed a treatment that transports 'tumour busting' genes selectively to cancer cells, according to a study published online in Cancer Research.
› Verified 7 days ago
| Entity Name | Muskingum Valley Health Centers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205018348 PECOS PAC ID: 4789760216 Enrollment ID: O20080618000216 |
News Archive
Baseball season has arrived, but no matter how eager young players are to get on the diamond they have to keep from overdoing it - especially if they're pitchers.
Chronic kidney disease (CKD) affects at least one in four Americans who are older than 60 and can significantly shorten lifespan. Yet the few available drugs for CKD can only modestly delay the disease's progress towards kidney failure. Now, however, a team led by researchers at the Perelman School of Medicine at the University of Pennsylvania, has found an aspect of CKD's development that points to a promising new therapeutic strategy.
A new model developed at MIT can help predict if patients at risk for Alzheimer's disease will experience clinically significant cognitive decline due to the disease, by predicting their cognition test scores up to two years in the future.
Nuance Communications, Inc. today announced PowerScribe 360, an advanced radiology reporting and communications platform that combines the best capabilities of PowerScribe and RadWhere into a unified solution. PowerScribe 360 was designed based on feedback and the extensive experience from Nuance's growing list of radiology customers, which today accounts for more than one third of all radiologists in the United States.
Cancer Research UK scientists have for the first time developed a treatment that transports 'tumour busting' genes selectively to cancer cells, according to a study published online in Cancer Research.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey D Downing, MD 945 Bethesda Dr, Ste 140, Zanesville, OH 43701-0801 Ph: (740) 454-4040 | Jeffrey D Downing, MD 945 Bethesda Dr, Ste 140, Zanesville, OH 43701-0801 Ph: (740) 454-4040 |
News Archive
Baseball season has arrived, but no matter how eager young players are to get on the diamond they have to keep from overdoing it - especially if they're pitchers.
Chronic kidney disease (CKD) affects at least one in four Americans who are older than 60 and can significantly shorten lifespan. Yet the few available drugs for CKD can only modestly delay the disease's progress towards kidney failure. Now, however, a team led by researchers at the Perelman School of Medicine at the University of Pennsylvania, has found an aspect of CKD's development that points to a promising new therapeutic strategy.
A new model developed at MIT can help predict if patients at risk for Alzheimer's disease will experience clinically significant cognitive decline due to the disease, by predicting their cognition test scores up to two years in the future.
Nuance Communications, Inc. today announced PowerScribe 360, an advanced radiology reporting and communications platform that combines the best capabilities of PowerScribe and RadWhere into a unified solution. PowerScribe 360 was designed based on feedback and the extensive experience from Nuance's growing list of radiology customers, which today accounts for more than one third of all radiologists in the United States.
Cancer Research UK scientists have for the first time developed a treatment that transports 'tumour busting' genes selectively to cancer cells, according to a study published online in Cancer Research.
› Verified 7 days ago
Dr. Jessica Martin Lafyatis, D.O Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 945 Bethesda Dr Ste 330, Zanesville, OH 43701 Phone: 740-454-8800 Fax: 740-454-7707 | |
Dr. Mitesh H. Parekh, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1210 Ashland Ave, Zanesville, OH 43701 Phone: 740-454-8551 | |
Dr. Callie Elyse Crider, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 945 Bethesda Dr Ste 330, Zanesville, OH 43701 Phone: 750-454-8800 | |
Dr. Kristy L Ritchie, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 945 Bethesda Dr, Ste 330, Zanesville, OH 43701 Phone: 740-454-8800 Fax: 740-454-7707 | |
Dr. Linda T Swan, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 945 Bethesda Drive, Suite 330, Zanesville, OH 43701 Phone: 740-454-8800 Fax: 740-454-7707 | |
Dr. Kristina L Loomis, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 945 Bethesda Drive, Suite 330, Zanesville, OH 43701 Phone: 740-454-8800 Fax: 740-454-7707 | |
John M Lepi, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 945 Bethesda Dr, Suite 120, Zanesville, OH 43701 Phone: 740-452-6778 Fax: 740-454-4770 |